Cargando...

The macrophage checkpoint CD47 : SIRPα for recognition of ‘self’ cells: from clinical trials of blocking antibodies to mechanobiological fundamentals

Immunotherapies against some solid tumour types have recently shown unprecedented, durable cures in the clinic, and the most successful thus far involves blocking inhibitory receptor ‘checkpoints’ on T cells. A similar approach with macrophages is emerging by blocking the ubiquitously expressed ‘mar...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Philos Trans R Soc Lond B Biol Sci
Autores principales: Andrechak, Jason C., Dooling, Lawrence J., Discher, Dennis E.
Formato: Artigo
Lenguaje:Inglês
Publicado: The Royal Society 2019
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6627025/
https://ncbi.nlm.nih.gov/pubmed/31431181
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1098/rstb.2018.0217
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!